Elutia (ELUT) Free Cash Flow (2019 - 2026)
Elutia (ELUT) reported Free Cash Flow of -$8.3 million for Q1 2026, up 9.83% on a YoY basis from -$7.5 million in Q1 2025, and up 67.82% sequentially from -$25.7 million in Q4 2025.
Elutia (ELUT) Free Cash Flow (2019 - 2026) Analysis & Trends
Elutia (ELUT) has 8 years of Free Cash Flow data on file, last reported at -$8.3 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow rose 9.83% year-over-year to -$8.3 million; the trailing twelve-month figure through Mar 2026 stood at -$45.8 million (down 53.57% YoY), and the FY2025 full-year result was -$46.7 million, down 100.27% from the prior year.
- Free Cash Flow grew to -$8.3 million in Q1 2026, from -$25.7 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$2.5 million in Q2 2023 to a low of -$25.7 million in Q4 2025.
- A 5-year average of -$7.6 million and a median of -$5.6 million in 2022 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow sank 1113.18% in 2022 and surged 77.42% in 2023, its largest moves.
- Tracing ELUT's Free Cash Flow over 5 years: stood at -$5.4 million in 2022, then tumbled by 69.18% to -$9.1 million in 2023, then plunged by 35.73% to -$12.4 million in 2024, then tumbled by 107.79% to -$25.7 million in 2025, then jumped by 67.82% to -$8.3 million in 2026.
- Business Quant data shows ELUT's Free Cash Flow at -$8.3 million in Q1 2026, -$25.7 million in Q4 2025, and -$3.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 449.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 305.56 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 112.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Elutia | 39.99 Mn | 11.50 Mn | 1.80 Mn | -8.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.26 Mn |
| Mar 31, 2026 | -8.26 Mn |
| Dec 31, 2025 | -25.66 Mn |
| Dec 31, 2025 | -25.66 Mn |
| Sep 30, 2025 | -3.53 Mn |
| Sep 30, 2025 | -3.53 Mn |
| Jun 30, 2025 | -8.33 Mn |
| Jun 30, 2025 | -8.33 Mn |
| Mar 31, 2025 | -9.16 Mn |
| Mar 31, 2025 | -9.16 Mn |
| Dec 31, 2024 | -12.35 Mn |
| Dec 31, 2024 | -12.35 Mn |
| Sep 30, 2024 | -3.97 Mn |
| Sep 30, 2024 | -3.97 Mn |
| Jun 30, 2024 | -4.33 Mn |
| Jun 30, 2024 | -4.33 Mn |
| Mar 31, 2024 | -2.66 Mn |
| Mar 31, 2024 | -2.66 Mn |
| Dec 31, 2023 | -9.10 Mn |
| Dec 31, 2023 | -9.10 Mn |